Antibody-drug conjugates-related interstitial lung diseases: data mining of the FAERS database
The signals of ILD AE associated with ADCs are notably strong. ILD should be closely monitored and assessed in the clinical use of ADCs taking full account of the efficacy and risks of these drugs.
Authors
- Xiaolan Liao (ORCID: https://orcid.org/0000-0001-9110-3934)
- Zicheng Yu (ORCID: https://orcid.org/0000-0003-2358-2712)
- Haibin Zhu
Institutions
- Tongji University (CN)
- Yangpu Hospital of Tongji University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1080/14740338.2024.2401025
- Citations
- 5
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 1.41